Works matching IS 03656233 AND DT 2023 AND VI 356 AND IP 10
Results: 14
Editorial Board: Arch Pharm (10/2023).
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 10, p. 1, doi. 10.1002/ardp.202370020
- Publication type:
- Article
Cover Picture: Arch Pharm (10/2023).
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 10, p. 1, doi. 10.1002/ardp.202370019
- Publication type:
- Article
Biological evaluation of [4‐(4‐aminophenyl)‐1‐(4‐fluorophenyl)‐1H‐pyrrol‐3‐yl](3,4,5‐trimethoxyphenyl)methanone as potential antineoplastic agent in 2D and 3D breast cancer models.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 10, p. 1, doi. 10.1002/ardp.202300354
- By:
- Publication type:
- Article
6‐Aminocoumarin oxime‐ether/sulfonamides as selective hCA IX and XII inhibitors: Synthesis, evaluation, and molecular dynamics studies.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 10, p. 1, doi. 10.1002/ardp.202300316
- By:
- Publication type:
- Article
The design, synthesis, biological evaluation, and molecular docking of new 5‐aminosalicylamide‐4‐thiazolinone hybrids as anticancer agents.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 10, p. 1, doi. 10.1002/ardp.202300315
- By:
- Publication type:
- Article
The medicinal panorama of benzimidazoles and their scaffolds as anticancer and antithrombotic agents: A review.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 10, p. 1, doi. 10.1002/ardp.202300206
- By:
- Publication type:
- Article
Optimization of 4‐amino‐pyridazin‐3(2H)‐one as a valid core scaffold for FABP4 inhibitors.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 10, p. 1, doi. 10.1002/ardp.202300314
- By:
- Publication type:
- Article
Liposomal formulation of model pentathiepin improves solubility and stability toward glutathione while preserving anticancer activity.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 10, p. 1, doi. 10.1002/ardp.202300087
- By:
- Publication type:
- Article
Design, synthesis, antimicrobial activity and molecular docking study of cationic bis‐benzimidazole‐silver(I) complexes.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 10, p. 1, doi. 10.1002/ardp.202300302
- By:
- Publication type:
- Article
Indole derivatives targeting colchicine binding site as potential anticancer agents.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 10, p. 1, doi. 10.1002/ardp.202300210
- By:
- Publication type:
- Article
Harnessing pyrimidine as a building block for histone deacetylase inhibitors.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 10, p. 1, doi. 10.1002/ardp.202300208
- By:
- Publication type:
- Article
hERG stereoselective modulation by mexiletine‐derived ureas: Molecular docking study, synthesis, and biological evaluation.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 10, p. 1, doi. 10.1002/ardp.202300116
- By:
- Publication type:
- Article
Development of 1‐(2‐aminophenyl)pyrrole‐based amides acting as human topoisomerase I inhibitors.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 10, p. 1, doi. 10.1002/ardp.202300270
- By:
- Publication type:
- Article
Synthesis, characterization and evaluation of anti‐hyperalgesia, anticonvulsant and antioxidant activity of novel VV‐hemorphin‐5 analogs.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 10, p. 1, doi. 10.1002/ardp.202300267
- By:
- Publication type:
- Article